KR830006230A - 신규트리-치환된이미다졸 유도체의 제조방법 - Google Patents

신규트리-치환된이미다졸 유도체의 제조방법 Download PDF

Info

Publication number
KR830006230A
KR830006230A KR1019810002709A KR810002709A KR830006230A KR 830006230 A KR830006230 A KR 830006230A KR 1019810002709 A KR1019810002709 A KR 1019810002709A KR 810002709 A KR810002709 A KR 810002709A KR 830006230 A KR830006230 A KR 830006230A
Authority
KR
South Korea
Prior art keywords
formula
compound
salt
group
amino
Prior art date
Application number
KR1019810002709A
Other languages
English (en)
Other versions
KR850000883B1 (ko
Inventor
살만 알프레드
Original Assignee
아놀드 자일러, 에른스트 알테르
시바-가이기 에이지
에른스트 알테르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아놀드 자일러, 에른스트 알테르, 시바-가이기 에이지, 에른스트 알테르 filed Critical 아놀드 자일러, 에른스트 알테르
Publication of KR830006230A publication Critical patent/KR830006230A/ko
Priority to KR1019840005963A priority Critical patent/KR850000886B1/ko
Priority to KR1019840005960A priority patent/KR850000873B1/ko
Priority to KR1019840005965A priority patent/KR850000888B1/ko
Priority to KR1019840005971A priority patent/KR850000892B1/ko
Priority to KR1019840005972A priority patent/KR850001064B1/ko
Priority to KR1019840005970A priority patent/KR850000911B1/ko
Priority to KR1019840005969A priority patent/KR850000891B1/ko
Priority to KR1019840005961A priority patent/KR850000884B1/ko
Priority to KR1019840005964A priority patent/KR850000887B1/ko
Priority to KR1019840005968A priority patent/KR850000890B1/ko
Priority to KR1019840005962A priority patent/KR850000885B1/ko
Priority to KR1019840005966A priority patent/KR850000889B1/ko
Application granted granted Critical
Publication of KR850000883B1 publication Critical patent/KR850000883B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

신규트리-치환된이미다졸 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 다음 일반식(Ⅱ)의 화합물에 임의의 추가 결합을 도입시키는 반면 이화합물 또는 토오토머체 및/또는 그의 염은 로부터 H-Z를 분리하거나 다음 일반식(V)의 화합물중 R3'기를 R3기로 전환시키거나 다음 일반식(Ⅵ)의 화합물 또는 그의 염증 R4를 수소로 전환시키거나 다음 일반식(Ⅶa)의 화합물 또는 그의 토오토머체를 다음 일반식(Ⅶb)의 화합물 또는 다음 일반식(Ⅷ)의 화합물 또는 그의 이성체와 반응시키고 필요하다면 본 제법에 따라 수득될 수 있는 유리 화합물을 염으로 전환시키거나 본 제법에 따라 수득될 수 있는 염을 유리 화합물 또는 다른 염으로 전환시키고 또는 필요하다면 본 발명에 따라 수득될 수 있는 일반식(I)의 이성체 화합물의 혼합물을 개별 이성체로 분리시킴을 특징으로 하여 다음 일반식(I)의 화합물 이들의 이성체 및 염을 제조하는 방법.
    상기식에서
    R1및 R2는 서로 다른 카보사이클릭 아릴 및 헤테로아릴을 나타내며
    A는 2원자가 탄화수소기를 나타내며
    R3는 카복시, 에스테르화된 카복시 또는 아미드화된 카복시를 나타내며 (단, A가 메틸렌 또는 에틸리덴을 나타내고 R3가 에톡시카보닐을 나타내며 R1및 R2중 적어도 하나는 페닐이 아니며 또한 A가 에틸리덴을 나타내고 R3가 카복시를 나타내며 -R1및 R2중 적어도 하나는 페닐, P-메톡시페닐 및 P-클로로페닐이 아니다)
    Y1및 Y6는 중 하나는 하이드록시 또는 아미노를 나타내며, 나머지 라디칼 및 Y2는 각각 수소를 나타내고 Y3는 Y4및 Y5와 함께=N-그룹을 나타내거나, Y1과 Y6함께 결합을 이루고 Y2는 수소를 Y3는 하이드록시 또는 아미노를 나타내고 Y4는 Y5와 함께 -NH- 그룹을 나타내거나, Y1과 Y6함께 결합을 이루고 Y2는 Y3와 함께 추가 결합을 나타내고 Y4및 Y5중 하나는 아미노를 나머지는 아미노, 하이드록시 또는 반응성 에스테르화 하이드록시 특히 할로겐 또는 설포닐옥시를 나타내거나, Y1은 하이드록시를 Y2및 Y3는 각각 수소를 Y4는 하이드록시 또는 아미노를 Y5는 Y6과 함께=NH 그룹을 나타내거나 Y4가 만일 아미노이면 옥소 또는 이미노를 나타내며,
    R3'는 R3로 전환될 수 있는 기를 나타내며,
    R4는 수소로 전환될 수 있는 기를 나타낸다.
  2. 다음 일반식(Ⅲa)의 디케톤을 가열하면서 다음 일반식(Ⅲb)의 알데하이드 또는 그의 염 및 과량의 암모니아와 반응시키거나 다음 일반식(Ⅲc)의 아실화된 α-아미노-케톤 또는 그의 염을 암모니아와 반응시키거나 다음 일반식(Ⅲh)의 화합물 또는 그의 염을 다음 일반식(Ⅲi)의 산유도체와 반응시키거나 다음 일반식(Ⅲd)의 화합물 또는 그의 염을 다음 일반식(Ⅲe)의 화합물 또는 그의 암모니아와의 염과 반응시키거나 다음 일반식(Ⅲf)의 옥사졸을 암모니아와 반응시킴을 특징으로 하는 특허청구범위 1에 따르는 방법.
    상기 식에서
    R1,R2,R3및 A는 전술된 바와같으며
    Z1은 반응성 에스테르화 하이드록시를 나타내며
    Z2는 아미디노기 또는 암모늄 카복실레이트를 나타낸다.
  3. 다음 일반식(Ⅲd)의 화합물을 다음 일반식(Ⅲp)의 카복실산 그의 염 또는 그의 작용성 유도체 및 암모니아와 반응시키거나 일반식(Ⅲd)의 화합물을 일반식(Ⅲp)의 화합물의 작용성 유도체와 반응시켜 수득할 수 있는 다음 일반식(Ⅲq)의 화합물을 암모니아와 반응시키고 필요하다면 이 방법으로 얻을 수 있는 일반식(Ⅲf)의 화합물중 N-산화되지 않는 헤테로아릴기 R1및 R2를 산화제 존재하에 N-산화시키고 필요하다면 본 제법에 따라 수득될 수 있는 유리화합물을 염으로 전환시키거나 본제법에 따라 수득할 수 있는 염을 유리화합물 또는 다른 염으로 전환시키고/또는 필요하다면 본 발명에 따라 수득할 수 있는 일반식(I)의 이성체화합물을 개별 이성체로 분리시킴을 특징으로 하여 다음 일반식(Ⅲf)의 화합물 이들의 이성체 및 염을 제조하는 방법.
    상기 식에서
    R1및 R2는 헤테로아릴 및 기타 카로사이클릭 아릴 또는 헤테로아릴을 나타내며
    A는 2원자가 탄화수소기를 나타내며
    R3는 카복시, 에스테르화된 카복시 또는 아미드화된 카복시를 나타낸다.
    (단, 헤테로아릴 R1또는 R2는 푸릴 및 티에닐이 아니다)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810002709A 1980-07-25 1981-07-25 삼-치환 이미다졸 유도체의 제조방법 KR850000883B1 (ko)

Priority Applications (12)

Application Number Priority Date Filing Date Title
KR1019840005969A KR850000891B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005961A KR850000884B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005965A KR850000888B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005971A KR850000892B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005972A KR850001064B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005970A KR850000911B1 (ko) 1980-07-25 1984-09-27 삼-치환 옥사졸 유도체의 제조방법
KR1019840005963A KR850000886B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005960A KR850000873B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005964A KR850000887B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005968A KR850000890B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005962A KR850000885B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005966A KR850000889B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH571580 1980-07-25
CH5715/80-5 1980-07-25

Related Child Applications (12)

Application Number Title Priority Date Filing Date
KR1019840005968A Division KR850000890B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005972A Division KR850001064B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005964A Division KR850000887B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005960A Division KR850000873B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005966A Division KR850000889B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005961A Division KR850000884B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005970A Division KR850000911B1 (ko) 1980-07-25 1984-09-27 삼-치환 옥사졸 유도체의 제조방법
KR1019840005969A Division KR850000891B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005963A Division KR850000886B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005965A Division KR850000888B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005971A Division KR850000892B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005962A Division KR850000885B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR830006230A true KR830006230A (ko) 1983-09-20
KR850000883B1 KR850000883B1 (ko) 1985-06-26

Family

ID=4298165

Family Applications (13)

Application Number Title Priority Date Filing Date
KR1019810002709A KR850000883B1 (ko) 1980-07-25 1981-07-25 삼-치환 이미다졸 유도체의 제조방법
KR1019840005970A KR850000911B1 (ko) 1980-07-25 1984-09-27 삼-치환 옥사졸 유도체의 제조방법
KR1019840005969A KR850000891B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005968A KR850000890B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005963A KR850000886B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005971A KR850000892B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005960A KR850000873B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005962A KR850000885B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005961A KR850000884B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005972A KR850001064B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005965A KR850000888B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005966A KR850000889B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005964A KR850000887B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법

Family Applications After (12)

Application Number Title Priority Date Filing Date
KR1019840005970A KR850000911B1 (ko) 1980-07-25 1984-09-27 삼-치환 옥사졸 유도체의 제조방법
KR1019840005969A KR850000891B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005968A KR850000890B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005963A KR850000886B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005971A KR850000892B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005960A KR850000873B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005962A KR850000885B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005961A KR850000884B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005972A KR850001064B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005965A KR850000888B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005966A KR850000889B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법
KR1019840005964A KR850000887B1 (ko) 1980-07-25 1984-09-27 삼-치환 이미다졸 유도체의 제조방법

Country Status (23)

Country Link
US (1) US4447431A (ko)
EP (1) EP0045081B1 (ko)
JP (1) JPS5756466A (ko)
KR (13) KR850000883B1 (ko)
AR (1) AR230269A1 (ko)
AT (1) ATE17349T1 (ko)
AU (2) AU7340481A (ko)
CA (1) CA1175431A (ko)
DD (2) DD201677A5 (ko)
DE (1) DE3173434D1 (ko)
DK (1) DK331881A (ko)
ES (8) ES8301472A1 (ko)
FI (1) FI812326L (ko)
GB (1) GB2080805B (ko)
GR (1) GR75287B (ko)
IE (1) IE52071B1 (ko)
IL (1) IL63410A (ko)
NO (1) NO812542L (ko)
NZ (1) NZ197828A (ko)
PL (8) PL237005A1 (ko)
PT (1) PT73424B (ko)
SU (8) SU1235454A3 (ko)
ZA (1) ZA815078B (ko)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983002613A1 (en) * 1981-07-20 1983-08-04 Sallmann, Alfred Trisubstituted oxazo compounds
EP0084756A1 (de) * 1982-01-22 1983-08-03 Ciba-Geigy Ag Trisubstituierte Oxazaverbindungen
FR2633291B1 (fr) * 1988-06-27 1990-09-07 Oreal Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant
US5252322A (en) * 1989-09-22 1993-10-12 The Gillette Company Skin tanning compositions containing imidazoles
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
IL104369A0 (en) * 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
JPH09505055A (ja) 1993-11-08 1997-05-20 スミスクライン・ビーチャム・コーポレイション サイトカイン媒介疾患治療用オキサゾール
US5723477A (en) * 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
ZA9610687B (en) * 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
JP2000503302A (ja) * 1996-01-11 2000-03-21 スミスクライン・ビーチャム・コーポレイション 新規置換イミダゾール化合物
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
EP0889888A4 (en) * 1996-03-25 2003-01-08 Smithkline Beecham Corp NEW TREATMENT OF LESIONS IN THE CENTRAL NERVOUS SYSTEM
EP0956018A4 (en) 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
AU7138298A (en) * 1997-04-24 1998-11-13 Ortho-Mcneil Corporation, Inc. Substituted imidazoles useful in the treatment of inflammatory diseases
AU7966198A (en) 1997-06-13 1998-12-30 Smithkline Beecham Corporation Novel pyrazole and pyrazoline substituted compounds
US6610695B1 (en) 1997-06-19 2003-08-26 Smithkline Beecham Corporation Aryloxy substituted pyrimidine imidazole compounds
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
CA2295762A1 (en) 1997-07-02 1999-01-14 Ravi Shanker Garigipati Novel cycloalkyl substituted imidazoles
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
EP1041989A4 (en) 1997-10-08 2002-11-20 Smithkline Beecham Corp NEW SUBSTITUTED CYCLOALCENYL COMPOUNDS
WO1999032121A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
KR20010025087A (ko) * 1998-05-22 2001-03-26 스튜어트 알. 수터 신규한 2-알킬 치환된 이미다졸 화합물
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
CA2341370A1 (en) * 1998-08-20 2000-03-02 Smithkline Beecham Corporation Novel substituted triazole compounds
EP1126852B1 (en) * 1998-11-04 2004-01-21 SmithKline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
MXPA02005106A (es) 1999-11-22 2002-11-07 Smithkline Beecham Plc Compuestos novedosos.
JP2003514900A (ja) 1999-11-23 2003-04-22 スミスクライン・ビーチャム・コーポレイション ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
US6759410B1 (en) 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
DE60015599T2 (de) 1999-11-23 2005-11-03 Smithkline Beecham Corp. 3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN
JP2003528043A (ja) 1999-11-23 2003-09-24 スミスクライン・ビーチャム・コーポレイション ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４‐ジヒドロ−（１Ｈ）キナゾリン−２−オン化合物
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
WO2001066539A1 (en) * 2000-03-06 2001-09-13 Smithkline Beecham P.L.C. Imidazol derivatives as raf kinase inhibitors
GB0005357D0 (en) 2000-03-06 2000-04-26 Smithkline Beecham Plc Compounds
IL155367A0 (en) * 2000-10-23 2003-12-23 Smithkline Beecham Corp NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
EP1432703A1 (en) * 2001-09-05 2004-06-30 Smithkline Beecham Plc Heterocycle-carboxamide derivatives as raf kinase inhibitors
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
JP2006525320A (ja) * 2003-05-08 2006-11-09 アステラス製薬株式会社 Ｃｏｘ阻害剤
PE20100737A1 (es) 2005-03-25 2010-11-27 Glaxo Group Ltd Nuevos compuestos
EP1865959A2 (en) * 2005-03-25 2007-12-19 Glaxo Group Limited Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558645A (en) * 1968-07-08 1971-01-26 Sandoz Ag 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
CH561718A5 (ko) * 1971-05-10 1975-05-15 Ciba Geigy Ag
GB1469532A (en) * 1973-06-28 1977-04-06 Dumex Ltd As Imimdazolyl-alkanoic acid derivatives
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols

Also Published As

Publication number Publication date
KR850000891B1 (ko) 1985-06-26
KR850002752A (ko) 1985-05-15
KR850000889B1 (ko) 1985-06-26
ATE17349T1 (de) 1986-01-15
PL237005A1 (en) 1983-02-28
KR850000890B1 (ko) 1985-06-26
IL63410A0 (en) 1981-10-30
GR75287B (ko) 1984-07-13
DD201677A5 (de) 1983-08-03
PL236997A1 (en) 1983-01-03
EP0045081A2 (de) 1982-02-03
ZA815078B (en) 1982-07-28
US4447431A (en) 1984-05-08
SU1235454A3 (ru) 1986-05-30
KR850002744A (ko) 1985-05-15
ES514585A0 (es) 1983-07-01
NO812542L (no) 1982-01-26
AU7340481A (en) 1982-01-28
SU1205763A3 (ru) 1986-01-15
KR850000885B1 (ko) 1985-06-26
SU1205764A3 (ru) 1986-01-15
CA1175431A (en) 1984-10-02
KR850000887B1 (ko) 1985-06-26
KR850000892B1 (ko) 1985-06-26
KR850002747A (ko) 1985-05-15
ES514581A0 (es) 1983-05-16
GB2080805A (en) 1982-02-10
ES504257A0 (es) 1982-12-01
ES8306124A1 (es) 1983-05-16
ES8306123A1 (es) 1983-05-16
AR230269A1 (es) 1984-03-01
KR850000884B1 (ko) 1985-06-26
ES514583A0 (es) 1983-05-16
ES514579A0 (es) 1983-05-16
KR850002756A (ko) 1985-05-15
ES8306121A1 (es) 1983-05-16
PL135822B1 (en) 1985-12-31
SU1145928A3 (ru) 1985-03-15
KR850000886B1 (ko) 1985-06-26
PL237003A1 (en) 1983-02-28
ES8306119A1 (es) 1983-05-16
PL232352A1 (ko) 1982-12-20
ES8306122A1 (es) 1983-05-16
PT73424B (en) 1983-06-20
PL237004A1 (en) 1983-02-28
ES514582A0 (es) 1983-05-16
SU1169534A3 (ru) 1985-07-23
PL237000A1 (en) 1983-02-28
KR850002749A (ko) 1985-05-15
SU1227112A3 (ru) 1986-04-23
PL237002A1 (en) 1983-02-28
AU5655586A (en) 1986-09-11
DE3173434D1 (en) 1986-02-20
EP0045081B1 (de) 1986-01-08
KR850002746A (ko) 1985-05-15
JPS5756466A (en) 1982-04-05
PL237001A1 (en) 1983-02-28
ES514584A0 (es) 1983-05-16
NZ197828A (en) 1985-11-08
KR850002753A (ko) 1985-05-15
KR850000883B1 (ko) 1985-06-26
KR850002750A (ko) 1985-05-15
KR850000888B1 (ko) 1985-06-26
GB2080805B (en) 1984-03-07
DD202554A5 (de) 1983-09-21
ES514580A0 (es) 1983-05-16
KR850002745A (ko) 1985-05-15
IE52071B1 (en) 1987-06-10
PT73424A (en) 1981-08-01
FI812326L (fi) 1982-01-26
SU1138023A3 (ru) 1985-01-30
ES8306120A1 (es) 1983-05-16
ES8301472A1 (es) 1982-12-01
ES8307245A1 (es) 1983-07-01
IL63410A (en) 1986-04-29
KR850000911B1 (ko) 1985-06-27
SU1152520A3 (en) 1985-04-23
KR850000873B1 (ko) 1985-06-22
DK331881A (da) 1982-01-26
KR850002754A (ko) 1985-05-15
KR850002748A (ko) 1985-05-15
EP0045081A3 (en) 1982-04-07
IE811680L (en) 1982-01-25
KR850001064B1 (ko) 1985-07-25
KR850002755A (ko) 1985-05-15

Similar Documents

Publication Publication Date Title
KR830006230A (ko) 신규트리-치환된이미다졸 유도체의 제조방법
KR840004074A (ko) 피리딘 또는 피란 디카복실산 유도체의 제조방법
KR840004406A (ko) 히단토인의 제조방법
KR840007011A (ko) 세펨 화합물의 제조방법
KR840007882A (ko) 디히드로피리딘 유도체 및 그 제법
KR830005257A (ko) 알도헥소즈 유도체의 제조방법
EP0263464A3 (de) Verfahren zur Herstellung von substituierten Pyridinen
KR850007601A (ko) 페남 유도체의 제조방법
KR950702188A (ko) 아미노산 유도체 생산 및 합성의 신규 중간체
ATE170184T1 (de) Verfahren zur herstellung von n-3-(1h-imidazol-1- yl)- phenyl-4-(substituierten)-2-pyrimidinaminen
KR840001946A (ko) 페놀 유도체의 제조방법
DE69318546T2 (de) Verfahren zur herstellung von prostaglandin e
KR830008489A (ko) N-아실 아미노산 유도체의 제조방법
Yamaji et al. The synthesis of 2-aza-adenosine-3′, 5′-cyclic phosphate via 1, N 6-etheno-adenosine-3′, 5′-cyclic phosphate
IE36684L (en) Anthranilic acid derivatives
GB1224323A (en) Amidothionophosphoric acid substituted phenyl esters
DE69123742D1 (de) Verfahren zur herstellung von 2-methyl-3,5-dialkylpyridinen durch dealkylierung mit schwefel
DK159432C (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
KR850006177A (ko) 신남산 유도체의 제조방법
ATE9477T1 (de) Verfahren zur herstellung von 1,1'-diacetalen.
KR900011777A (ko) 신규한 아미노 카르복실산 유도체
RU95105585A (ru) Способ получения амидов 3,3-диарилакриловой кислоты
JPS6413074A (en) Production of 2, 5-piperazinedione derivative
ES2053992T3 (es) Proceso para la sintesis de antocianidinas y nuevos intermedios producidos en dichos procesos.
CA2059689A1 (en) Process for producing carboxylated compound